- Home
- INSP vs PATH Comparison
INSP vs PATH Comparison
Compare INSP & PATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INSP
- PATH
- Stock Information
- Founded
- INSP 2007
- PATH 2005
- Country
- INSP United States
- PATH United States
- Employees
- INSP N/A
- PATH N/A
- Industry
- INSP Medical/Dental Instruments
- PATH Computer Software: Prepackaged Software
- Sector
- INSP Health Care
- PATH Technology
- Exchange
- INSP Nasdaq
- PATH Nasdaq
- Market Cap
- INSP 5.3B
- PATH 5.9B
- IPO Year
- INSP 2018
- PATH 2021
- Fundamental
- Price
- INSP $159.46
- PATH $10.30
- Analyst Decision
- INSP Buy
- PATH Hold
- Analyst Count
- INSP 11
- PATH 20
- Target Price
- INSP $228.82
- PATH $12.97
- AVG Volume (30 Days)
- INSP 423.9K
- PATH 14.7M
- Earning Date
- INSP 05-06-2025
- PATH 03-12-2025
- Dividend Yield
- INSP N/A
- PATH N/A
- EPS Growth
- INSP N/A
- PATH N/A
- EPS
- INSP 1.75
- PATH N/A
- Revenue
- INSP $802,804,000.00
- PATH $1,429,664,000.00
- Revenue This Year
- INSP $20.65
- PATH $13.10
- Revenue Next Year
- INSP $17.49
- PATH $10.51
- P/E Ratio
- INSP $90.72
- PATH N/A
- Revenue Growth
- INSP 28.49
- PATH 9.30
- 52 Week Low
- INSP $123.00
- PATH $9.50
- 52 Week High
- INSP $257.40
- PATH $22.83
- Technical
- Relative Strength Index (RSI)
- INSP 39.43
- PATH 33.60
- Support Level
- INSP $162.35
- PATH $10.52
- Resistance Level
- INSP $172.95
- PATH $11.41
- Average True Range (ATR)
- INSP 6.80
- PATH 0.44
- MACD
- INSP -0.25
- PATH 0.03
- Stochastic Oscillator
- INSP 30.91
- PATH 29.55
About INSP Inspire Medical Systems Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
About PATH UiPath Inc.
UiPath offers an end-to-end cross-application enterprise automation platform. The platform leverages a range of automation technologies including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries including claims processing, employee onboarding, invoice to cash, loan applications, and customer service.